Leverage patient-reported data and PROMs to improve outcomes in oncology

Bridge the gap between traditional and holistic care

For pharmaceutical companies, the integration and utilisation of Patient Reported Outcomes (PROs) data in oncology care presents unique opportunities. This data can demonstrate patient-centred care, enhance brand value, differentiate in a competitive market, and foster patient trust. PROs are bridging the gap between traditional clinical endpoints and providing a more holistic approach to care. This leads to improved overall patient outcomes.

This paper explores:

• The role of PROs in oncology care
• Impact on patient outcomes and brand perception
• Challenges in integrating and utilising patient-reported data
• Strategies for effective integration of PROs and Patient Reported Outcome Measures (PROMs)
• Pharma’s role in optimising patient-reported data

Download this free paper to understand the essential role of PROs and PROMs in cancer care and subsequent benefits to Pharma.